ArticleDiseases (Basel, Switzerland)2025

Immunological Monitoring During Anti-CD20 Therapies to Predict Infection Risk and Treatment Response in Multiple Sclerosis Patients.

Gabriel Torres Iglesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.